Victory Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

Victory Capital Management’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-284,332	Closed	-$39.8M	–	1929
2018 Q4	$39.8M	Sell	284,332 -65,740	-19%	-$9.98M	0.1%	311
2018 Q3	$59.8M	Sell	350,072 -13,315	-4%	-$2.24M	0.12%	253
2018 Q2	$63M	Sell	363,387 -81,935	-18%	-$12.3M	0.13%	221
2018 Q1	$51.4M	Sell	445,322 -5,625	-1%	-$598K	0.11%	285
2017 Q4	$38M	Buy	450,947 +15,155	+3%	+$1.26M	0.08%	400
2017 Q3	$40.1M	Sell	435,792 -364,680	-46%	-$28.3M	0.09%	357
2017 Q2	$64.2M	Sell	800,472 -531,570	-40%	-$29.5M	0.15%	211
2017 Q1	$56.1M	Sell	1,332,042 -149,079	-10%	-$6.14M	0.13%	263
2016 Q4	$47.6M	Sell	1,481,121 -129,213	-8%	-$3.31M	0.12%	311
2016 Q3	$42.2M	Buy	+1,610,334	New	+$42.1M	0.12%	298

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Victory Capital Management's LOXO Position: Q1 2019 in Review

Victory Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 284,332 shares — an estimated $39.8M sold.

Victory Capital Management first reported a position in LOXO in Q3 2016 and held it in 10 quarters. The position peaked at $64.2M in Q2 2017. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Victory Capital Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Victory Capital Management sold 284,332 Loxo Oncology, Inc shares in Q1 2019, an estimated $39.8M.
Victory Capital Management first reported a position in Loxo Oncology, Inc in Q3 2016 and held it in 10 quarters.
Victory Capital Management's Loxo Oncology, Inc position peaked at $64.2M in Q2 2017.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Victory Capital Management's 13F filing for Q1 2019, filed 3 May 2019.